Search Results 891-900 of 18376 for alopecia

  1. INCB161734 For Advanced Or Metastatic Solid Tumors With KRAS G12D Mutation - Mayo Clinic

    ... alopecia) are exceptions and may enroll. For participants in Parts 2a and 2b who will be receiving retifanlimab as part of this study: immune-related ...

  2. Mayo Clinic

    There's still time! ... Hurry to 3X your gift's impact on cancer research and care! Triple My Impact.

  3. A Study to Evaluate Regorafenib with Cetuximab or Panitumumab to Treat Unresectable, Locally Advanced, or Metastatic Colorectal Cancer - Mayo Clinic

    0 grade 1 attributed to any prior therapy/procedure excluding alopecia and oxaliplatin induced neurotoxicity ≤ grade 2. Albumin levels < 2.5 g/dl; Any of ...

  4. Mayo Clinic

    Hurry to 3X your gift's impact on cancer research and care! Triple My Impact · Find a doctor · Explore careers · Sign up for free e-newsletters ...

  5. Head and neck cancers - Doctors and departments - Mayo Clinic

    Learn about innovative treatment for throat cancers, mouth cancers, tongue cancers, tonsil cancers and other cancers that affect the head and neck.

  6. Head and neck cancers - Doctors and departments - Mayo Clinic

    Learn about innovative treatment for throat cancers, mouth cancers, tongue cancers, tonsil cancers and other cancers that affect the head and neck.

  7. (QuANTUM-R): An Open-label Study of Quizartinib Monotherapy vs. Salvage Chemotherapy in Acute Myeloid Leukemia (AML) Subjects Who Are FLT3-ITD Positive - Mayo Clinic

    (QuANTUM-R): An Open-label Study of Quizartinib Monotherapy vs. Salvage Chemotherapy in Acute Myeloid Leukemia (AML) Subjects Who Are FLT3-ITD Positive. Print ...

  8. Combination Study of SV-BR-1-GM in Combination With INCMGA00012 and Retifanlimab - Mayo Clinic

    Toxicity of prior therapy that has not recovered to ≤ Grade 1 or baseline (with the exception of any grade of alopecia and anemia not requiring transfusion ...

  9. A Study to Evaluate Setmelanoitide to Treat Patients with Rare Genetic Disorders of Obesity - Mayo Clinic

    The purpose of this study is to explore the impact of Setmelanotide on obesity in patients with various specific rare genetic mutations. Participation ...

  10. Oral AMXT 1501 Dicaprate in Combination With IV DFMO - Mayo Clinic

    ... alopecia, etc.). Patients who have an ongoing requirement for thyroid replacement therapy from prior exposure to a checkpoint inhibitor but who are ...